Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Dimethyl Fumarate
100%
Multiple Sclerosis
100%
Treatment Discontinuation
50%
Denmark
37%
Norway
30%
Reasons for Discontinuation
28%
Discontinuation Rate
24%
Hazard Ratio
20%
Adverse Events
14%
Lymphopenia
14%
Patient Characteristics
10%
Young Age
10%
Relapse Rate
10%
Disease Duration
10%
Relapsing-remitting multiple Sclerosis
10%
Female Sex
10%
Disease-modifying Therapy
10%
Quality of Life
10%
Disease Burden
10%
Expanded Disability Status Scale
10%
Medicine and Dentistry
Fumaric Acid Dimethyl Ester
100%
Multiple Sclerosis
100%
Adverse Event
21%
Hazard Ratio
20%
Diseases
17%
Lymphocytopenia
14%
Disease Burden
10%
Patient Characteristics
10%
Quality of Life
10%
Recurrence Risk
10%
Expanded Disability Status Scale
10%
Disease Duration
10%
Disease Activity
7%
Survival Analysis
7%
Population Research
7%
Treatment Duration
7%
Health Care Cost
7%
Log Rank Test
7%
